Litcius/Paper detail

Cytochrome P450 1A2 overcomes nuclear factor kappa B-mediated sorafenib resistance in hepatocellular carcinoma

Jianqing Yu, Nuozhou Wang, Zhongqin Gong, Liping Liu, Shengli Yang, George G. Chen, Paul B.S. Lai

2020Oncogene32 citationsDOI

Topics & Concepts

SorafenibHepatocellular carcinomaCYP1A2Cancer researchBiologyDownregulation and upregulationApoptosisCell growthPharmacologyCytochrome P450EndocrinologyBiochemistryMetabolismGeneHepatocellular Carcinoma Treatment and PrognosisDrug-Induced Hepatotoxicity and ProtectionCytokine Signaling Pathways and Interactions
Cytochrome P450 1A2 overcomes nuclear factor kappa B-mediated sorafenib resistance in hepatocellular carcinoma | Litcius